Results for tag: "Basaglar"

Basaglar is a type of endocrine and metabolic disorder drug used to treat type 1 and type 2 diabetes. It is a long-acting insulin analog that helps to control blood sugar levels. It works by mimicking the action of natural insulin in the body, helping to reduce the amount of sugar in the blood. Basaglar is administered through an injection, either subcutaneously or intramuscularly. It is typically taken once a day, although the dosage may vary depending on the individual's needs. Basaglar is a relatively new drug, having been approved by the FDA in 2014. It is marketed by Eli Lilly and Company, and is available in both the United States and Europe. Other companies that produce similar drugs include Novo Nordisk, Sanofi, and Merck. Basaglar is also available in generic form, with several generic manufacturers offering the drug. Show Less Read more